Pharmicell Co (XKRX:005690) Other Operating Expense : ₩4,879 Mil (TTM As of Mar. 2024)

View and export this data going back to 1988. Start your Free Trial

What is Pharmicell Co Other Operating Expense?

Pharmicell Co's Other Operating Expense for the three months ended in Mar. 2024 was ₩1,216 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩4,879 Mil.

Pharmicell Co's quarterly Other Operating Expense increased from Sep. 2023 (₩1,106 Mil) to Dec. 2023 (₩1,434 Mil) but then declined from Dec. 2023 (₩1,434 Mil) to Mar. 2024 (₩1,216 Mil).

Pharmicell Co's annual Other Operating Expense declined from Dec. 2021 (₩6,300 Mil) to Dec. 2022 (₩5,648 Mil) and declined from Dec. 2022 (₩5,648 Mil) to Dec. 2023 (₩4,685 Mil).

Pharmicell Co Other Operating Expense Historical Data

The historical data trend for Pharmicell Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmicell Co Other Operating Expense Chart

Pharmicell Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

4,532.50

4,729.28

6,300.25

5,648.49

4,685.38

Pharmicell Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															1,022.72	1,122.14	1,106.19	1,434.33	1,216.14

Pharmicell Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩4,879 Mil.

Pharmicell Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Pharmicell Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmicell Co (XKRX:005690) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmicell Co Ltd (XKRX:005690) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

12F Chungho B/D, 3-2 Nonhyun-dong Gangnam-gu, Seoul, KOR, 135-010

Website

http://www.pharmicell.com

Pharmicell Co Ltd is a biotechnology company, engages in the manufacturing of biopharmaceutical medicines in South Korea. Its biopharmaceutical business engages in the development and manufacture of stem cell therapeutic drugs and stem cell-based cosmetics and others. Its products under development include mesenchymal stem cell products, such as Cellgram_AMI, a heart disease drug; Cellgram_IS and Cellgram_SCI, which are brain/nerve disorder drugs; Cellgram_Lung, a pulmonary disease drug; Cellgram_LC, a liver disease drug; and Cellgram_ED and Cellgram_CLI for the treatment of graft-versus-host disease, kidney transplant, impotence, and critical lower limb ischemia.

Pharmicell Co (XKRX:005690) Headlines

No Headlines